CYAD

Celyad Oncology SA American Depositary Shares

Delisted

CYAD was delisted on the 18th of May, 2023.

12 hedge funds and large institutions have $19.3M invested in Celyad Oncology SA American Depositary Shares in 2018 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 5 increasing their positions, 2 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
12
Holders Change
Holders Change %
0%
% of All Funds
0.27%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
2
Increased
5
Reduced
2
Closed
2
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Shares
Change %
Victory Capital Management
1
Victory Capital Management
Texas
$16.4M +$452K +17,160 +3%
Millennium Management
2
Millennium Management
New York
$1.41M +$913K +34,645 +184%
SLG
3
Stanley-Laman Group
Pennsylvania
$1.05M +$32.5K +1,225 +3%
Wells Fargo
4
Wells Fargo
California
$160K +$147K +5,545 +1,109%
Deutsche Bank
5
Deutsche Bank
Germany
$155K -$7.31K -275 -5%
Morgan Stanley
6
Morgan Stanley
New York
$106K +$43.5K +1,635 +70%
UBS Group
7
UBS Group
Switzerland
$48K -$158 -6 -0.3%
AG
8
Advisor Group
Arizona
$21K +$21K +800 New
PA
9
Parallel Advisors
California
$7K +$7K +281 New
Zurich Cantonal Bank
10
Zurich Cantonal Bank
Switzerland
$3K
US Bancorp
11
US Bancorp
Minnesota
$2K
Bank of Montreal
12
Bank of Montreal
Ontario, Canada
$2K
EP
13
Eversept Partners
New York
-$382K -12,840 Closed
Renaissance Technologies
14
Renaissance Technologies
New York
-$205K -6,900 Closed